Astrotech Reports Second Quarter of Fiscal Year 2018 Financial Results
Austin, TX - February 8, 2018 -
Astrotech (NASDAQ: ASTC) reported its financial results for the second quarter of fiscal year 2018 ended December 31, 2017.
“In the second quarter of fiscal year 2018, we made further progress under the Cooperative Research and Development Agreement we previously signed with the Department of Homeland Security Science and Technology Directorate Transportation Security Laboratory by demonstrating 1st Detect’s mass spectrometry-based explosives and narcotics detector, the TRACER 1000, to government personnel,” said Thomas B. Pickens, III, Chairman and CEO of Astrotech. “We also showcased the product at the Border Security Expo to our target audience of government, border, immigration, and law enforcement agencies. The TRACER 1000, we believe, will be a considerable improvement over the current generation of ion mobility spectrometry-based explosives trace detector instrumentation. We anticipate deploying in airport security, to keep our borders safe from terroristic threats, and to help combat the opioid epidemic. We are currently working on attaining certification of our product with the Transportation Security Administration.
“In addition, in the fiscal second quarter, Astral Images was chosen by a large post-production film company to remove defects and restore a motion picture. Astral continues to be positioned to lead the 4K UHD/HDR conversion and restoration of film as global adoption of 4K UHD/HDR televisions ramps up and demand for 4K HDR content and services grows,” Mr. Pickens concluded.
Second Quarter Fiscal Year 2018 Financial Highlights
Revenue, costs of goods sold, SG&A, and R&D are expected to continue to fluctuate based on the timing of projects.
Revenue was $41 thousand, which was generated from a software license agreement with a large post-production film company to correct defects and restore one film. •
Gross profit was $17 thousand, or 41%, for the second quarter of fiscal 2018.
At December 31, 2017, cash and investments were $9.2 million, and there was no debt.
Astrotech Corporation (NASDAQ: ASTC) is an innovative science and technology company that invents, acquires, and commercializes technological innovations sourced from research institutions, laboratories, universities, and internally, and then funds, manages, and builds proprietary, scalable start-up companies for profitable divestiture to market leaders to maximize shareholder value. Sourced from Oak Ridge Laboratory’s chemical analyzer research, 1st Detect develops, manufactures, and sells chemical analyzers for use in the security, defense, healthcare, food and beverage, and environmental markets. Sourced from decades of image research from the laboratories of IBM and Kodak, Astral Images sells film-to-digital image enhancement, defect removal and color correction software, and post processing services providing economically feasible conversion of television and feature 35mm and 16mm films to the new 4K ultra-high definition (UHD), high-dynamic range (HDR) format necessary for the new generation of digital distribution. Sourced from NASA’s extensive microgravity research, Astrogenetix is applying a fast-track, on-orbit discovery platform using the International Space Station to develop vaccines and other therapeutics. Demonstrating its entrepreneurial strategy, Astrotech management sold its state-of-the-art satellite servicing operations to Lockheed Martin in August 2014. Astrotech has operations throughout Texas and is headquartered in Austin.
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, whether we can successfully develop our proprietary technologies and whether the market will accept our products and services, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. The Company assumes no obligation to update these forward-looking statements.
Chief Financial Officer